Ulrich Mrowietz (U Mrowietz)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 36

Top Topics

Atopic Dermatitis

Top Venues

Journal of the European Academy of Dermatology and Venereology : JEADV

The British journal of dermatology

Psoriasis (Auckland, N.Z.)

JMIR research protocols

This page only lists publications with an associated author ORCID identifier.

Publications

María José Valencia López, Brigitte Stephan, Anna Meineke, Sandra Wolf, Diamant Thaҫi, Ulrich Mrowietz, Valerie Andrees, Stephan Jeff Rustenbach, Kristian Reich, Linus Thalmann, Henriette Bogena, Petra Staubach-Renz, Ralph Michael von Kiedrowski, Matthias Augustin
Perception and Impact of COVID-19 Pandemic in Psoriasis Patients: Data from the German PsoBest and the CoronaBest Registries. Psoriasis (Auckland, N.Z.) 14 (2024)
María José Valencia López, Brigitte Stephan, Anna Meineke, Sandra Wolf, Diamant Thaҫi, Ulrich Mrowietz, Valerie Andrees, Stephan Jeff Rustenbach, Kristian Reich, Linus Thalmann, Henriette Bogena, Petra Staubach-Renz, Ralph Michael von Kiedrowski, Matthias Augustin
Perception and Impact of COVID-19 Pandemic in Psoriasis Patients: Data from the German PsoBest and the CoronaBest Registries. Psoriasis (Auckland, N.Z.) 14 (2024)
Rachel Sommer, Ulrich Mrowietz, Kristian Gaarn du Jardin, Ismail Kasujee, Elisa Martini, Esteban Daudén, Gabriella Fabbrocini, Alexander Zink, Christopher Ernest Maitland Griffiths, Matthias Augustin
Implementing wellbeing in the management of psoriasis: An expert recommendation. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
M Valencia López, A Meineke, Brigitte Stephan, S Rustenbach, A Kis, D Thaci, Ulrich Mrowietz, K Reich, P Staubach-Renz, R von Kiedrowski, H Bogena, Matthias Augustin
SARS-CoV-2 vaccination status and adverse events among patients with psoriasis - data from the German Registries PsoBest and CoronaBest. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Ulrich Mrowietz, M Sümbül, Sascha Gerdes
Depression, a major comorbidity of psoriatic disease, is caused by metabolic inflammation. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Rachel Sommer, L Westphal, Ulrich Mrowietz, Sascha Gerdes, Matthias Augustin
Measuring well-being in psoriasis: psychometric properties of the WHO-5 questionnaire. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (12) (2022)
Christine Blome, Catharina C Braren-von Stülpnagel, Matthias Augustin, Ulrich Mrowietz, Kristian Reich, Holger Muehlan, Natalia Kirsten, Anna K Langenbruch, Christina Sorbe, Toni Maria Janke
Measuring patient-relevant benefits in the treatment of psoriasis with the Patient Benefit Index: development and preliminary validation of a 10-item short form. The British journal of dermatology 187 (4) (2022)
Kristian Reich, L Iversen, Lluis L Puig, J Lambert, Ulrich Mrowietz, K Kaplan Saday, R B Warren
Long-term efficacy and safety of brodalumab in moderate-to-severe plaque psoriasis: a post hoc pooled analysis of AMAGINE-2 and -3. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (8) (2022)
Nikolas Ruffer, Heinrich Haberstock, Ann-Sophie Bohne, Ina Koetter, Ulrich Mrowietz
Papulonodular tattoo lesions as a clinical sign of systemic sarcoidosis. Clinical rheumatology 41 (8) (2022)
Ulrich Mrowietz, Matthias Augustin
Using the upgrade criteria of the European Psoriasis Consensus is best practice care according to the people-centred healthcare concept of the World Health Organization. The British journal of dermatology 187 (6) (2022)
Ulrich Mrowietz, Jonathan Barker, Curdin Conrad, Denis Jullien, Paolo Gisondi, Andrea Flower, Jyotsna Reddy, Maria Paris, Hernan Picard, Shauna Jardon, Matthias Augustin
Efficacy and safety of apremilast in patients with limited skin involvement, plaque psoriasis in special areas and impaired quality of life: Results from the EMBRACE randomized trial. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
P J Morrison, I Suhrkamp, Sascha Gerdes, Ulrich Mrowietz
Oral dimethyl fumarate induces changes within the peripheral neutrophil compartment of patients with psoriasis that are linked with skin improvement. The British journal of dermatology 185 (3) (2021)
Ulrich Mrowietz, T Dieckmann, S Gerdes, S Szymczak, R von Spreckelsen, A Körber
ActiPso: definition of activity types for psoriatic disease: A novel marker for an advanced disease classification. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (10) (2021)
Anna K Langenbruch, Nicole Zander, Natalia Kirsten, Kristian Reich, R von Kiedrowski, K Strömer, Ulrich Mrowietz, Matthias Augustin
Quality of psoriasis care in Germany - results from the nationwide health care studies PsoHealth 2004-2017. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (7) (2021)
Ulrich Mrowietz, R B Warren, C L Leonardi, D Saure, H Petto, S Hartz, M Dossenbach, Kristian Reich
Network meta-analysis of biologic treatments for psoriasis using absolute Psoriasis Area and Severity Index values ≤1, 2, 3 or 5 derived from a statistical conversion method. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (5) (2021)
J Shourick, Charles Taïeb, Julien Seneschal, S Merhand, Khaled Ezzedine, Bruno Halioua, M A Richard, Ulrich Mrowietz
EczemaPartner - adapting a questionnaire to assess the impact of atopic dermatitis on partners of patients. Journal of the European Academy of Dermatology and Venereology : JEADV (2021)
A Leutz, Andreas Pinter, D Thaçi, Matthias Augustin, C Schuster, K Fotiou, H P Hundemer, D Saure, Ulrich Mrowietz, Kristian Reich
Efficacy and safety of ixekizumab after switching from fumaric acid esters or methotrexate in patients with moderate-to-severe plaque psoriasis naïve to systemic treatment. The British journal of dermatology 184 (3) (2020)
J C Ehrenthal, S Woeste, Ulrich Mrowietz, S Gerdes, Christian Graetz
Profiles of psychosocial variables and dental status in patients with psoriasis. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (10) (2020)
Matthias Augustin, E Dauden, Ulrich Mrowietz, Maria-Polina Konstantinou, S Gerdes, M Rissler, S Gathmann, C Sieder, D Baeumer, R Orsenigo
Baseline characteristics of patients with moderate-to-severe psoriasis according to previous systemic treatment exposure: the PROSE study population. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (11) (2020)
Rachel Sommer, Janine Topp, Ulrich Mrowietz, Nicole Zander, Matthias Augustin
Perception and determinants of stigmatization of people with psoriasis in the German population. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (12) (2020)
Andreas Pinter, M Hoffmann, Kristian Reich, Matthias Augustin, K Kaplan, S D Gudjónsdóttir, T Delvin, Ulrich Mrowietz, null null
A phase 4, randomized, head-to-head trial comparing the efficacy of subcutaneous injections of brodalumab to oral administrations of fumaric acid esters in adults with moderate-to-severe plaque psoriasis (CHANGE). Journal of the European Academy of Dermatology and Venereology : JEADV 35 (3) (2020)
Kristian Reich, A Körber, Ulrich Mrowietz, Michael Sticherling, C Sieder, J Früh, T Bachhuber
Secukinumab 2-weekly vs. 4-weekly dosing in patients with plaque-type psoriasis: results from the randomized GAIN study. The British journal of dermatology 184 (5) (2020)
Matthias Augustin, Esteban Daudén, Ulrich Mrowietz, Maria-Polina Konstantinou, S Gerdes, K Kingo, Jacek Cezary Szepietowski, J L Perrot, A Cuccia, M Rissler, S Gathmann, C Sieder, R Orsenigo, P Jagiello, T Bachhuber
Secukinumab treatment leads to normalization of quality of life and disease symptoms in psoriasis patients with or without prior systemic psoriasis therapy: the PROSE study results. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (2) (2020)
Alexander Egeberg, Paolo Gisondi, Y José Manuel Carrascosa, R B Warren, Ulrich Mrowietz
The role of the interleukin-23/Th17 pathway in cardiometabolic comorbidity associated with psoriasis. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (8) (2020)
Kristian Reich, J Sullivan, P Arenberger, S Jazayeri, Ulrich Mrowietz, Matthias Augustin, Boni E Elewski, R You, P Regnault, J A Frueh
Secukinumab shows high and sustained efficacy in nail psoriasis: 2.5-year results from the randomized placebo-controlled TRANSFIGURE study. The British journal of dermatology 184 (3) (2020)
Nicole Zander, M Naatz, Matthias Augustin, Anna K Langenbruch, Janine Topp, Ulrich Mrowietz, R von Kiedrowski, M Krensel, D Jungen, Natalia Kirsten
Determinants of costs and benefits in psoriasis routine care: results from a cross-sectional nationwide study in Germany. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (1) (2020)
Janine Topp, V Andrees, N A Weinberger, I Schäfer, Rachel Sommer, Ulrich Mrowietz, C Luck-Sikorski, Matthias Augustin
Strategies to reduce stigma related to visible chronic skin diseases: a systematic review. Journal of the European Academy of Dermatology and Venereology : JEADV 33 (11) (2019)
Gregor Borut Ernst Jemec, M M Okun, S B Forman, W P F Gulliver, E P Prens, Ulrich Mrowietz, April W Armstrong, Z Geng, Y Gu, D A Williams, H D Teixeira, A B Kimball
Adalimumab medium-term dosing strategy in moderate-to-severe hidradenitis suppurativa: integrated results from the phase III randomized placebo-controlled PIONEER trials. The British journal of dermatology 181 (5) (2019)
Ulrich Mrowietz
Psoriasis, stress, age and more. The British journal of dermatology 178 (4) (2019)
Kristian Reich, J L K Reich, T M Falk, N Blödorn-Schlicht, Ulrich Mrowietz, R von Kiedrowski, C Pfeiffer, J Niesmann, Y Frambach, R B Warren
Clinical response of psoriasis to subcutaneous methotrexate correlates with inhibition of cutaneous T helper 1 and 17 inflammatory pathways. The British journal of dermatology 181 (4) (2019)
P C M van de Kerkhof, R Loewe, Ulrich Mrowietz, M Falques, I Pau-Charles, Jacek Cezary Szepietowski
Quality of life outcomes in adults with moderate-to-severe plaque psoriasis treated with dimethylfumarate (DMF): a post hoc analysis of the BRIDGE study. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (1) (2019)
R B Warren, J N W Barker, P Van de Kerkhof, K Reich, Ulrich Mrowietz
Switching from a fumaric acid ester mixture to dimethylfumarate monotherapy in psoriasis. Journal of the European Academy of Dermatology and Venereology : JEADV 33 (10) (2019)
Jördis Maria Zill, Jörg Dirmaier, Matthias Augustin, Sarah Dwinger, Eva Christalle, Martin Härter, Ulrich Mrowietz
Psychosocial Distress of Patients with Psoriasis: Protocol for an Assessment of Care Needs and the Development of a Supportive Intervention. JMIR research protocols 7 (2) (2018)
R Bissonnette, T Luger, D Thaçi, D Toth, A Lacombe, S Xia, R Mazur, M Patekar, P Charef, M Milutinovic, C Leonardi, Ulrich Mrowietz
Secukinumab demonstrates high sustained efficacy and a favourable safety profile in patients with moderate-to-severe psoriasis through 5 years of treatment (SCULPTURE Extension Study). Journal of the European Academy of Dermatology and Venereology : JEADV 32 (9) (2018)
Antonios G A Kolios, A J Hueber, P Michetti, Ulrich Mrowietz, M Mustak-Blagusz, P-G Sator, M Reinshagen, D Wilsmann-Theis, S Gomis-Kleindienst, U Luckey, A Rössler, I Schiefke
ALIGNed on adherence: subanalysis of adherence in immune-mediated inflammatory diseases in the DACH region of the global ALIGN study. Journal of the European Academy of Dermatology and Venereology : JEADV 33 (1) (2018)
Ulrich Mrowietz, J Barker, W-H Boehncke, L Iversen, B Kirby, Luigi Naldi, K Reich, A Tanew, P C M van de Kerkhof, R B Warren
Clinical use of dimethyl fumarate in moderate-to-severe plaque-type psoriasis: a European expert consensus. Journal of the European Academy of Dermatology and Venereology : JEADV (2018)